MedQIA, WorldCare Clinical and DARC, have come together to form Voiant, the industry’s leading clinical trial imaging solution provider with unparalleled scientific and clinical domain expertise. Voiant’s unique AI-based software platform integrates all aspects of clinical trial imaging, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data. For more information, go to https://www.voiantclinical.com/

At SSI Strategy, we're strategic partners deeply invested in our clients' success. We offer a unique, adaptive approach to supporting biotech companies, integrating business acumen with deep expertise in Clinical Development & Operations, Regulatory affairs, Pharmacovigilance, Medical Affairs, Quality and more.

Our agile skills and resources model allows us to adapt to your specific needs, working as an embedded team within your organization. We complement your existing teams, scaling specialized skill sets up and down as needed, while equipping them with the tools and resources to operate at peak performance. By fostering the organization you want to build, we position your full-time employees to be more successful and effective in their strengths. As your needs evolve, so does our support. We offer deep expertise, strategic insight, and a comprehensive range of services to help you navigate the challenges of bringing a therapeutic from concept to commercialization.

Our mission is clear: Build better biotechs through seamless collaboration, informed decision-making, and accelerated progress.

For more information, please visit www.ssistrategy.com

Learn more at: https://corval.io/

Founded in 2000, BioSearch Recruiting is a retained executive search firm focused on placing leaders of R&D, Clinical Development, Medical Affairs, Regulatory Affairs and CMC. We specialize in CMO searches and building clinical organizations, including physicians at all levels and leaders across key functions. From nimble start-ups to established global enterprises, we partner closely with our clients to attract top talent, identify cultural fit and create high impact teams. Please visit us at: https://www.biosearchrecruiting.com/

TrialHub is the preferred clinical trial intelligence platform of leading Biopharmaceutical and CRO companies. TrialHub provides real-time data updates from 80,000 sources and turns them into unparalleled insights helping trial experts choose the best patient-centric strategies for country and site selection, ensuring recruitment can be completed on budget and on time. To learn more, visit trialhub.com or follow us on LinkedIn. To learn more, please visit https://trialhub.com/

Kayentis, a global leader in eCOA and Decentralized Clinical Trial solutions, empowers pharma, biotech, and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency, and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in diverse therapeutic areas. Adapting to the changing landscape, Kayentis now offers a comprehensive suite of services to support the shift towards decentralized and hybrid trials, with operational capabilities across the USA, Europe, and Asia. To learn more, please visit https://kayentis.com/

PCI is a leading global CDMO, providing integrated end-to-end drug development, manufacturing and packaging solutions, increasing product speed to market and commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of supply chain pharmaceutical services. With 30 sites globally, our mission is to collaborate with our clients and deliver life-changing therapies to patients. To learn more, please visit https://pci.com/

Alira Health is a global healthcare firm whose mission is to humanize healthcare and life sciences in partnership with patients. From development to medical care, we complement the expertise of our pharma, biotech, and medtech clients with a full spectrum of services across their entire solutions lifecycle, including clinical operations, real-world evidence, and patient-centric technology offerings. Featured solutions include Decentralized Clinical Trials, Patient Support Programs, Digital Therapeutics, and Real-World Evidence. Our global team is comprised of over 800 scientists, strategists, economists, clinicians, and biostatisticians who collaborate to fully understand every aspect of our clients’ business and offer value at every stage of their corporate and product evolution. We advise 80% of the top 50 of medtech companies and 75% of the top 50 of pharma companies. Headquartered in Framingham (MA, U.S.), we also have offices in Toronto (Canada), Paris and Bordeaux (France), Munich (Germany), Bologna, Milan, and Verona (Italy), Zevenbergen (Netherlands), Barcelona (Spain), Basel (Switzerland), London (UK), and Sydney (Australia). To learn more, please visit https://alirahealth.com/

MUNIT is operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics. In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy). Our services: • Jet- , Pin- and Hammer milling • Cryogenic Micronization • Co- micronization • Sieving, Blending, De-Lumping • Technical trials, DoE Studies, Process development and validation • QbD • PSD analysis etc. To learn more, please visit https://www.munit.com/

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. To learn more, please visit www.signanthealth.com

We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded and proprietary, LTS-funded projects. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. For more information, visit www.ltslohmann.com

Learn more at https://www.precisionformedicine.com/